Companies / Romania
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Actavis Romania Outlines Strategy
May 2007 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
The Romania subsidiary of Icelandic generics behemoth Actavis is intending to doubles sales within the next three years and establish itself as the third largest player in its domestic market. While Actavis Romania will have the invaluable backing - both financial and know-how - of its parent company to achieve these aims, it BMI's view that the firm will fall slightly short of these ambitious goals, given that the impressive recent growth witnessed in the Romanian market will inevitable contract in the